• babban_banner_01

Melanotan II

Takaitaccen Bayani:

Abubuwan API:
Babban tsarki ≥ 99%
Haɗa ta hanyar haɗakar peptide mai ƙarfi-lokaci (SPPS)
Low endotoxin, ƙananan sauran kaushi
Akwai a cikin R&D zuwa sikelin kasuwanci


Cikakken Bayani

Tags samfurin

Melanotan II API

Melanotan IIshine analog na heptapeptide synthetic cyclicα-melanocyte-stimulating hormone (α-MSH), ci gaba zuwainganta melanogenesis, ingantaKariyar UV, da daidaitawaayyukan jima'i da na rayuwa. Yana aiki azaman aagonist mara zabina masu karɓar melanocortin, musammanSaukewa: MC1R, Saukewa: MC3R, kumaSaukewa: MC4R.

Asali ya yi karatu domin satanningkumaphotoprotectiveProperties, Melanotan II ya kuma nuna tasiri a kaninganta libido, rage cin abinci, kumamakamashi balance, Yin shi peptide bincike na multifunctional tare da sha'awar dermatology, endocrinology, da magungunan jima'i.


Tsarin Aiki

Melanotan II yana aiki ta hanyar kunna masu karɓar melanocortin da yawa:

  • Saukewa: MC1R: Yana kara kuzarisamar da melanin→ yana ƙara launin fata da kariya ta UV

  • Saukewa: MC3R/MC4R: Shiga cikikula da ci, inganta libido, kumamakamashi homeostasis

  • Ketare shingen kwakwalwar jini, rinjayar tsakiyar neurohormonal hanyoyin


Bincike da Aikace-aikace masu yiwuwa

Kodayake ba a yarda da amfani da magani ba, Melanotan II ana nazarin ko'ina don masu zuwa:

1. Pigmentation Skin & Kariyar UV

  • Yana haɓakaeumelanin kira, kai gatanning na halitta

  • Yana bayarwatasirin kariya na hotoba tare da fallasa rana ba

  • Mai yuwuwa don rage haɗarin kansar fata a cikin mutane masu fata

2. Rashin Yin Jima'i

  • An nuna wayana kara sha'awa da sha'awar jima'ia cikin maza da mata

  • Ya yi karatu a matsayin mai yuwuwar magani gaRashin karfin mazakuta (ED)ta MC4R kunnawa

3. Ci abinci & Gudanar da nauyi

  • Mayurage ci da abincita hanyar yin aiki akan hanyoyin hypothalamic

  • Mai yuwuwar haɗin gwiwa a cikibinciken kiba


Siffofin API (ta Ƙungiyar Gentolex)

  • Babban tsarki ≥ 99%(HPLC & LC-MS sun tabbatar)

  • Haɗa ta hanyarTsarin peptide mai ƙarfi (SPPS)

  • Low endotoxin, ƙananan sauran kaushi

  • Akwai a cikiR&D zuwa sikelin kasuwanci


  • Na baya:
  • Na gaba:

  • Ku rubuta sakonku anan ku aiko mana